Strategic Partnership Opportunity to collaborate with Banham Poultry to scale Fe3C technology for Campylobacter reduction in poultry, aligning with food safety suppliers and animal health distributors to accelerate field trials and commercial adoption.

Addressable Market Significant cost savings and public health impact in Campylobacter management present a compelling value proposition for food producers, poultry processors, and cattle/wildlife infection prevention segments seeking broad-spectrum anti-biofilm solutions.

Early Stage Advantage Leverage Akeso’s Fe3C platform and Tufts silk biomaterial licensing to position as an innovative, differentiated technology, targeting early-stage pilot programs with grant-backed, proof-of-concept trials at pilot facilities.

Targeted Financing Recent financing round demonstrates investor interest; pursue strategic funding from agri-tech, life sciences, and government grant programs to expand manufacturing readiness and regulatory pathways.

Key Relationships Engage advisory and board-level connections in poultry and food safety sectors to open introductions to potential customers, distributors, and co-development opportunities that can accelerate validation and scale.